We present the latest insight and analysis of the rapidly evolving field of cancer therapeutics and immuno-therapy, with a particular focus on what current innovati
SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition, taking place on 1st-2nd April 2019 in London.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh